Brooklyn Investment Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$935K Buy
4,165
+1,713
+70% +$427K 0.03% 604
2025
Q4
$595K Buy
2,452
+1,053
+75% +$269K 0.03% 559
2025
Q3
$357K Sell
1,399
-35
-2% -$9.56K 0.05% 366
2025
Q2
$370K Buy
1,434
+342
+31% +$81.6K 0.05% 371
2025
Q1
$244K Buy
1,092
+181
+20% +$42.3K 0.05% 302
2024
Q4
$208K Buy
911
+68
+8% +$16.4K 0.06% 242
2024
Q3
$206K Buy
+843
New +$188K 0.07% 236

Other funds holding RMD

Brooklyn Investment Group's RMD Position: Q1 2026 in Review

Brooklyn Investment Group increased its ResMed (RMD) stake by 70% in Q1 2026, buying an estimated $427K and bringing the position to 4,165 shares worth $935K. The position accounts for 0.03% of the portfolio, ranked #604.

Brooklyn Investment Group first reported a position in RMD in Q3 2024 and has held it in 7 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Brooklyn Investment Group held 4,165 shares of ResMed worth $935K as of Q1 2026.
  • Brooklyn Investment Group bought 1,713 ResMed shares in Q1 2026, an estimated $427K.
  • ResMed made up 0.03% of Brooklyn Investment Group's portfolio in Q1 2026, its #604 holding.
  • Brooklyn Investment Group first reported a position in ResMed in Q3 2024 and has held it in 7 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.